Ikena Oncology Inc. (IKNA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.49
-0.02 (-1.32%)
At close: Jan 15, 2025, 12:02 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -1.21 | -1.44 | -13.22 | -25.92 | -68.22 | -28.07 |
PS Ratio | 8.98 | 6.16 | 14.56 | 124.78 | 83.42 | 1.16K |
PB Ratio | 0.48 | 0.65 | 2.17 | -11.35 | -18.67 | -25.03 |
P/FCF Ratio | -1.03 | -1.27 | -7.27 | -29.73 | 24.10 | -96.3 |
P/OCF Ratio | -1.03 | -1.3 | -7.49 | -30.33 | 23.94 | -98.83 |
OCF/S Ratio | -8.71 | -4.75 | -1.94 | -4.11 | 3.48 | -11.73 |
Debt / Equity Ratio | 0.06 | 0.04 | 0.03 | -0.00 | -1.28 | -1.37 |
Quick Ratio | 12.58 | 7.44 | 8.70 | 5.86 | 3.51 | 5.22 |
Current Ratio | 12.58 | 7.44 | 8.70 | 5.86 | 3.51 | 5.22 |
Asset Turnover | 0.05 | 0.09 | 0.13 | 0.05 | 0.16 | 0.05 |
Interest Coverage | n/a | -32.99 | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.4 | -0.45 | -0.16 | 0.44 | 0.27 | 0.89 |
Return on Assets (ROA) | -0.35 | -0.39 | -0.14 | -0.26 | -0.2 | -1.98 |
Return on Capital (ROIC) | -0.42 | -0.47 | -0.15 | -0.32 | -0.3 | -2.43 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 88.86% | 86.98% | -52.03% | -387.79% | -81.33% | -3.84K% |
Net Profit Margin | -744.17% | -426.6% | -110.1% | -481.36% | -122.28% | -4.13K% |
Pretax Profit Margin | -745.94% | -440.29% | -110.1% | -481.36% | -122.28% | -4.13K% |
Operating Profit Margin | -823.33% | -453.99% | -110.18% | -484.22% | -134.46% | -4.13K% |
FCF Margin | -875.08% | -483.67% | -200.14% | -419.75% | 346.19% | -1.20K% |
EBITDA Margin | -812.19% | -449.18% | -108.42% | -480.95% | -132.69% | -4.09K% |